Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Noevir is a prominent Japanese company specializing in the development, manufacture, and sale of high-end cosmetics, pharmaceuticals, and health foods. The company operates primarily through its Noevir and Tokiwa Pharmaceutical brands, focusing on botanical science and skin-care research to create natural-based products. Its pharmaceutical division produces a range of over-the-counter medicines, including cough drops and nutritional drinks, while its cosmetics arm is known for its direct-sales model and premium skincare lines. Noevir maintains a strong research presence, investigating plant extracts and fermentation technologies to enhance product efficacy. The company is publicly traded on the Tokyo Stock Exchange and serves both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Noevir.